• 15q26 deletion syndrome with pure red cell aplastic anemia: a case report
• A Case of Erythropoietin (EPO)-Induced Pure Red Cell Aplasia and Its Treatment Efficacy With Desidustat
• A Case of Oral Lichen Planus Preceding the Diagnosis of Good Syndrome
• A Case of Suspected Pure Red Cell Aplasia Due to Nivolumab Treatment for Unresectable Esophageal Cancer
• A case report on deficiency of adenosine deaminase 2 with relapse-remission course and analysis of genotype-phenotype correlation
• A case series of ten plus one deficiency of adenosine deaminase 2 (DADA2) patients in Iran
• A De Novo Frameshift Mutation in RPL5 with Classical Phenotype Abnormalities and Worsening Anemia Diagnosed in a Young Adult-A Case Report and Review of the Literature
• A late relapse thymoma and pure red cell aplasia case with an over 5 years of clinical response under everolimus
• A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia
• A riboflavin transporter deficiency presenting as pure red cell aplasia: a pediatric case report
• Bidirectional ABO Mismatch Is Associated With Elevated Mortality in Hematopoietic Stem Cell Transplantation: Insights From a Single-Center Experience
• Case report: Successful treatment with daratumumab for pure red cell aplasia in a patient with mixed lymphoid chimerism after ABO-mismatched stem cell transplant for sickle cell disease
• Clinical and immune features of human parvovirus B19 infection in allogeneic stem cell transplantation recipients: A retrospective monocentric study
• Clinical characteristics and prognosis of 21 patients with thymoma-associated pure red cell aplasia
• Comparison of Cyclosporine A and Cyclosporine A Combined with Corticosteroid in the Treatment of Acquired Pure Red Cell Aplasia
• Deficiency of Adenosine Deaminase 2
• Deficiency of Adenosine Deaminase 2: Clinical Manifestations, Diagnosis, and Treatment
• Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement
• Diamond-Blackfan anemia with very late and fatal onset aplasia in a 55-year-old patient with RPL11 mutation
• Diamond-Blackfan anemia, the archetype of ribosomopathy: How distinct is it from the other constitutional ribosomopathies?
• Effective treatment of refractory monoclonal gammopathy-associated pure red cell aplasia with isatuximab, pomalidomide and dexamethasone
• Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC
• Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data
• Elderly Male With Epstein-Barr Virus (EBV)-Induced Pure Red Cell Aplasia
• En mann i 40-årene med transfusjonskrevende anemi
• Et barn med langvarig anemi
• Functional autoantibodies: Definition, mechanisms, origin and contributions to autoimmune and non-autoimmune disorders
• Generation of iPSC lines and isogenic gene-corrected lines from two individuals with RPS19-mutated Diamond-Blackfan anemia syndrome
• Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report
• Good's Syndrome With Pure Red Cell Aplasia and Subclinical Myasthenia Gravis: A Case Report and Review of Literature
• Haploinsufficiency of the essential gene <em>Rps12</em> causes defects in erythropoiesis and hematopoietic stem cell maintenance
• Harnessing Single-Cell Technologies in the Search for New Therapies for Diamond-Blackfan Anemia Syndrome
• Hematologic Manifestations of Parvovirus B19 Infection
• High expression of NADH Ubiquinone Oxidoreductase Subunit B11 induces catheter-associated venous thrombosis on continuous blood purification
• HLA-B*46:01:01:01 and HLA-DRB1*09:01:02:01 are associated with anti-rHuEPO-induced pure red cell aplasia
• Identification of novel mutations in patients with Diamond-Blackfan anemia and literature review of RPS10 and RPS26 mutations
• Immune Checkpoint Inhibitor-Induced Pure Red Cell Aplasia: A Review of 2 Cases in Metastatic Melanoma
• Immune-mediated hemolytic anemia and pure red cell aplasia in a Jack Russell Terrier during treatment for hypoadrenocorticism
• Immuno-Hematologic Complexity of ABO-Incompatible Allogeneic HSC Transplantation
• Insights from a Case of Good's Syndrome (Immunodeficiency with Thymoma)
• Integrated proteogenomic analysis for inherited bone marrow failure syndrome
• Intravenous immunoglobulin treatment of congenital parvovirus B19 induced anemia - a case report
• Large granular lymphocytic leukemia and its association with immune dysregulation
• Lentivirus-mediated gene therapy corrects ribosomal biogenesis and shows promise for Diamond Blackfan anemia
• Monoclonal Gammopathy of Anemic Significance? Resolution of Pure Red Cell Aplasia With Daratumumab-Based Therapy
• Monolobated megakaryocytes in Diamond-Blackfan anemia with RPL5 mutation at disease presentation mimicking myelodysplastic syndrome
• Neuromyelitis Optica spectrum disorder complicated with pure red cell aplasia: a case report
• Niraparib-induced pure red cell aplasia
• Non-immune hydrops fetalis caused by Diamond-Blackfan anaemia and a mutation of the RPL15 gene
• Normal Erythroid Precursors in Diamond-Blackfan Anemia: A Rare Case Highlighting Challenges That Remain
• p53 in the Molecular Circuitry of Bone Marrow Failure Syndromes
• Patients with acquired pure red cell aplasia respond to PI3Kdelta inhibitor rapidly
• Perspectives of current understanding and therapeutics of Diamond-Blackfan anemia
• Positive response of a hemodialysis patient with pure red cell aplasia on recombinant human erythropoietin therapy to cyclosporine and Roxadustat
• Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review
• Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient With Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case Report
• Pure red cell aplasia and minimal residual disease conversion associated with immune reconstitution in a patient with high-risk multiple myeloma
• Pure Red Cell Aplasia Associated With Thymoma
• Pure Red Cell Aplasia Encountered in a Tertiary Care Hematology Laboratory: A Series of Nine Distinctive Cases
• Pure Red Cell Aplasia Induced by Atezolizumab in a Patient with Small-Cell Lung Cancer Successfully Treated with Steroid Therapy: A Case Report
• Pure red cell aplasia occurring during ibrutinib therapy for chronic lymphocytic leukemia
• Pure red cell aplasia secondary to erythropoietin therapy
• Pure Red Cell Aplasia Secondary to Parvovirus B19 Infection as a Rare Cause of Anemia in a Dialysis Patient: A Case Report
• Pure red cell aplasia: The second hundred years
• Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing/refractory multi-lineage autoimmune cytopenia
• Refractory Pure Red Blood Cell Aplasia Secondary to Major ABO-Incompatible Allogeneic Stem Cell Transplantation Successfully Treated With Daratumumab
• Refractory pure red cell aplasia associated with T-cell large granular lymphocyte leukemia treated by ruxolitinib
• Resistant anemia in a kidney transplant recipient: Pure red cell aplasia due to parvovirus B19 infection
• Role of Anti-CD38 Monoclonal Antibodies in the Treatment of Adult Immune Hematological Diseases
• Secondary Pure Red Cell Aplasia During Daratumumab/ Hyaluronidase Therapy for Multiple Myeloma
• Seronegative Rheumatoid Arthritis in an Elderly Dialysis Patient With Multiple Comorbidities: A Case Report
• Single-cell RNA sequencing reveals abnormal transcriptome signature of erythroid progenitors in pure red cell aplasia
• STK10 mutations block erythropoiesis in acquired pure red cell aplasia via impairing ribosome biogenesis
• Successful Clozapine Rechallenge After Clozapine-Induced Severe Anemia: A Case Report
• Successful treatment of a pure red cell aplasia patient following ABO-mismatched hematopoietic stem cell transplantation from a sibling donor with multiple sclerosis
• Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab
• T-cell large granular lymphocytic leukemia in Vietnam: Using microscope-to-screen videoconferencing to improve diagnosis
• T-cell large granular lymphocytic leukemia with low-grade bone marrow involvement complicated by acquired pure red cell aplasia
• Targeting of Calbindin 1 rescues erythropoiesis in a human model of Diamond Blackfan anemia
• The ghost of parvovirus past: Idiopathic pure red cell aplasia responding to IVIG following resolved perinatal parvovirus B19 infection
• The impact of infused red blood cell volume on major and bidirectional ABO-mismatched bone marrow transplantation
• The transcriptomic landscape of normal and ineffective erythropoiesis at single-cell resolution
• Thymic carcinoma presenting with overlap polyarthritis and myositis: A rare paraneoplastic syndrome in childhood
• Towards a Cure for Diamond-Blackfan Anemia: Views on Gene Therapy
• Transient erythroblastopenia due to a GATA1 variant in an infant female
• Transient erythroblastopenia of childhood after COVID-19 infection: a case report
• Treating Parvovirus Triggered Refractory Hemolytic Anemia with Rituximab in Renal Transplant Recipients - A Report of Two Cases
• Treatment of refractory/relapsed Diamond-Blackfan anaemia with eltrombopag
• Treatment strategy for acquired pure red cell aplasia: a systematic review and meta-analysis
• Two Unrelated Iranian Patients with Adenosine Deaminase 2 Deficiency: A Case Report and Review of Treatment
• Umbilical Cord Blood and UC-MSCs Combined with Low-Dose Immunosuppressant in the Treatment of Elderly Patients with Pure Red Cell Aplastic: A Case Series
• Understanding complex disease-related mechanisms: Rational therapies for Diamond-Blackfan anaemia
• Unearthing FLVCR1a: tracing the path to a vital cellular transporter
• Unusual Presentation of B-Cell Chronic Lymphocytic Leukemia Accompanied by Pure Red Cell Aplasia: Case Report
• Use of IV immunoglobulin to treat steroid resistant, immune checkpoint inhibitor-induced pure red cell aplasia: A case report
• Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: a case report